Cite
MLA Citation
Philipp Bernhard Staber et al.. “Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.” Leukemia & lymphoma, vol. 62, no. 14, 2021, pp. 3440–3451. http://access.bl.uk/ark:/81055/vdc_100147039000.0x000036